ZYFLO

Product NDC
10122-901
11-digit product format
101220901
Labeler code
10122
Product ID
10122-901_d49e40c7-0635-4220-8b0a-c5068116ee17
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
zileuton
Dosage form
TABLET
Route
ORAL
Labeler
Chiesi USA, Inc.
Application
NDA020471
Marketing category
NDA
Marketing start
1996-12-06
Marketing end
2027-11-30
Substance
ZILEUTON
Active strength
600 mg/1
Pharmacologic classes
5-Lipoxygenase Inhibitor [EPC], 5-Lipoxygenase Inhibitors [MoA], Decreased Leukotriene Production [PE]
NDC exclude flag
No
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020471-001ZYFLOZILEUTON300MGTABLET / ORALRLD1996-12-09
N020471-003ZYFLOZILEUTON600MGTABLET / ORALRLD1996-12-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N020471-001ZYFLO300MGTABLET / ORALRLD1996-12-09caaa826d4ba7…
2026-08-18 06:07:402026-07N020471-003ZYFLO600MGTABLET / ORALRLD1996-12-09caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020471-001ZYFLO300MGTABLET / ORALRLD1996-12-09011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020471-003ZYFLO600MGTABLET / ORALRLD1996-12-09011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020471-001ZYFLO300MGTABLET / ORALRLD1996-12-0931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020471-003ZYFLO600MGTABLET / ORALRLD1996-12-0931067a03dcf5…
2025-08-23 18:47 UTC2025-08N020471-001ZYFLO300MGTABLET / ORAL1996-12-096a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-096a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020471-001ZYFLO300MGTABLET / ORAL1996-12-09fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-09fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020471-001ZYFLO300MGTABLET / ORAL1996-12-09b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-09b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020471-001ZYFLO300MGTABLET / ORAL1996-12-0903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-0903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020471-001ZYFLO300MGTABLET / ORAL1996-12-092680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-092680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020471-001ZYFLO300MGTABLET / ORAL1996-12-095bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-095bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020471-001ZYFLO300MGTABLET / ORAL1996-12-09d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-09d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020471-001ZYFLO300MGTABLET / ORAL1996-12-09d06236e962d9…
2024-10-29 15:01 UTC2024-10N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-09d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020471-001ZYFLO300MGTABLET / ORAL1996-12-0979d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-0979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020471-001ZYFLO300MGTABLET / ORAL1996-12-09301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-09301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020471-001ZYFLO300MGTABLET / ORAL1996-12-091e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-091e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020471-001ZYFLO300MGTABLET / ORAL1996-12-098072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-098072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020471-001ZYFLO300MGTABLET / ORAL1996-12-095c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-095c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020471-001ZYFLO300MGTABLET / ORAL1996-12-095d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-095d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020471-001ZYFLO300MGTABLET / ORAL1996-12-094b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-094b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020471-001ZYFLO300MGTABLET / ORAL1996-12-0974a2ff9319b5…
2019-12-13 00:20 UTC2019-12N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-0974a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020471-001ZYFLO300MGTABLET / ORAL1996-12-09bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03N020471-003ZYFLO600MGTABLET / ORALRLD, RS1996-12-09bb7c543d1eb4…

Additional Listing Data#

Finished product
Yes
Brand name base
ZYFLO

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ZILEUTON600 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
V1L22WVE2SInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
199904Internal RxNorm lookup
211777Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
aee65202-fddb-497f-9f11-17cc727cb157Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ab1cd6a-2e03-4fd2-842b-497a1f1ff461Product name420231219
4fad46b7-5f43-5163-8976-8a0f23153295Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10122-901-12ZYFLO120 in 1 BOTTLETABLET12033

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10122-901-12EA - Each10122-9015e5bd7ef-9cdb-4c12-8ee7-ce540f3796b512012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ZILEUTONACTIVE INGREDIENTV1L22WVE2SZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
ZILEUTONACTIVE MOIETYV1L22WVE2SZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
CROSPOVIDONEINACTIVE INGREDIENT68401960MKZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
HYDROXYPROPYL CELLULOSE (TYPE H)INACTIVE INGREDIENTRFW2ET671PZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30ZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3ZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2ZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
TALCINACTIVE INGREDIENT7SEV7J4R1UZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]25

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10122-901ZYFLO (ZILEUTON) TABLET [CHIESI USA, INC.]30Current NDC, Legacy NDC, 1 package rows20220114_aee65202-fddb-497f-9f11-17cc727cb157.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZYFLOZILEUTONChiesi USA, Inc.aee65202-fddb-497f-9f11-17cc727cb1572025-11-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 020471
application number: NDA020471
ndc (product): 10122-901

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
199904zileuton 600 MG Oral TabletPSNaee65202-fddb-497f-9f11-17cc727cb15733
211777Zyflo 600 MG Oral TabletPSNaee65202-fddb-497f-9f11-17cc727cb15733
211777zileuton 600 MG Oral Tablet [Zyflo]SBDaee65202-fddb-497f-9f11-17cc727cb15733
199904zileuton 600 MG Oral TabletSCDaee65202-fddb-497f-9f11-17cc727cb15733
211777Zyflo 600 MG Oral TabletSYaee65202-fddb-497f-9f11-17cc727cb15733

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
10122-901-1210122090112120 TABLET in 1 BOTTLE (10122-901-12) 120 tablet1996-12-062027-11-30NoNoCurrent